Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Cash flows from operating activities:
Net loss	$ (7,580,240)	$ (7,691,771)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	47,495	66,604
Amortization of patents	53,013	814,681
Impairment to long lived assets		1,539,794
Stock compensation	183,888	409,021
Loss from earnings on China joint venture	(81,324)	(329,700)
Inventory reserve		543,545
Deferred cost reserve		1,250,928
Change in fair value of derivative liability	3,635,580
Amortization of right-of-use assets	155,962
Changes in operating assets and liabilities:
Decrease (Increase) in accounts receivable	267,791	(442,943)
Decrease (Increase) in accounts receivable, related party	100,000	(192,540)
(Increase) in other receivables	(9,027)
Decrease in inventories	300,542	914,613
(Increase) Decrease in advances on contracts	(61,879)	48,409
(Increase) Decrease in prepaid expenses and other current assets	(104,522)	21,869
Increase in accounts payable	320,239	227,773
(Decrease) Increase in accounts payable, related party	(303,346)	678,171
Decrease (Increase) in deferred cost, related party	50,000	(191,257)
Increase in accrued expenses	273,537	620,797
Increase (Decrease) in accrued expenses, related party	1,228,965	(108,640)
Decrease in operating lease liability	(155,962)
(Decrease) Increase in deferred revenue, related party	(100,000)	192,540
Net cash used in operating activities	(1,779,288)	(1,628,106)
Cash flows from investing activities:
Purchase of intangible assets
Purchase of property and equipment	(9,916)	(7,401)
Acquisition of Milestone Education		(8,020)
Net cash used in investing activities	(9,916)	(15,421)
Cash flows from financing activities:
Payments for financing transaction		(250,000)
Proceeds from exercise of warrants	337,500
Net proceeds from Public Placement Offering	1,974,547
Net proceeds from Private Placement Offering	250,000
Net cash provided by financing activities	2,562,047	(250,000)
Net increase (decrease) in cash and cash equivalents	772,843	(1,893,527)
Cash and cash equivalents at beginning of period	743,429	2,636,956
Cash and cash equivalents at end of period	1,516,272	743,429
Supplemental non-cash disclosure of cash flow information:
Shares issued to employee for bonuses	753,000
Shares issued to board of directors for services rendered	67,000
Shares issued to employees for compensation	37,500	45,000
Shares issued to consultants in lieu of cash payments	440,400	289,750
Sale of Milestone China share, financing transaction		(1,400,000)
Credit from United Systems for defective handpieces	(151,562)
Initial recognition of operating lease-right of use assets	(166,292)
Initial recognition of operating lease right to used liabilities	$ 166,292